乳腺外科数字化诊疗体系的构建与方向
陈小松负责资料收集和撰写;沈坤炜负责指导、审查和修订。所有作者均阅读并确认最终稿。
收稿日期: 2026-05-25
网络出版日期: 2026-08-11
Construction and direction of a digital diagnosis and treatment system in breast surgery
Received date: 2026-05-25
Online published: 2026-08-11
陈小松 , 沈坤炜 . 乳腺外科数字化诊疗体系的构建与方向[J]. 外科理论与实践, 2026 , 31(03) : 183 -184 . DOI: 10.16139/j.1007-9610.2026.03.01
Breast surgery diagnosis and treatment is gradually transitioning from multi-disciplinary management to digital, intelligent, and precision-based care. Multidimensional data generated during the diagnosis and treatment process—including imaging, pathology, genomics, clinical treatment, follow-up, and rehabilitation provides the foundation for a full-process digital diagnosis and treatment system. Supported by artificial intelligence (AI), cloud platforms, multimodal imaging fusion, and multi-omics integration, this system can cover screening, diagnosis, treatment decision-making, surgical planning, postoperative treatment, and long-term follow-up, thereby paving the way for the digital, intelligent, and precision-based transformation of breast surgery.
| [1] | Eisemann N, Bunk S, Mukama T, et al. Nationwide real-world implementation of AI for cancer detection in population-based mammography screening[J]. Nat Med, 2025, 31(3):917-924. |
| [2] | Elías-Cabot E, Romero-Martín S, Raya-Povedano J L, et al. AI-based triage and decision support in mammography and digital tomosynthesis for breast cancer screening: a paired, noninferiority trial[J]. Nat Med, 2026, 32(4):1296-1305. |
| [3] | Zheng X, Yao Z, Huang Y, et al. Deep learning radiomics can predict axillary lymph node status in early-stage breast cancer[J]. Nat Commun, 2020, 11(1):1236. |
| [4] | Olawade D B, Oisakede E O, Bello O J, et al. Digital twins in oncology: from predictive modelling to personalised treatment strategies[J]. Crit Rev Oncol Hematol, 2026, 220:105171. |
| [5] | Frenel J S, Heudel P E, Guinaudeau E, et al. Treatment-aware deep learning enables counterfactual prediction of individual benefit from PARP inhibitors in ovarian cancer[J]. NPJ Digit Med, 2026,20. |
/
| 〈 |
|
〉 |